Human Pharmaceutical Portfolio

Fosapretero 150 mg Injection

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthFosaprepitant 150 mg
ManufacturerHetero Healthcare Ltd
CategoryNausea
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.